The APhA Academy of Pharmaceutical Research and Science (APhA-APRS) stimulates the discovery, dissemination and application of research to improve patient health and serves pharmacists and those members who are involved in the pharmaceutical sciences.

Created with Sketch.

APhA-APRS News and Highlights
Call for 2018-2019 APhA-APRS Standing Committee Members

Looking for opportunities to get involved in APhA and the Academies, grow your professional network and build leadership skills? APhA-APRS is seeking member volunteers to serve on several Academy Committees. Benefits of becoming an Academy volunteer include opportunities to provide input on programs and products offered by the Association, support the profession by addressing emerging issues, learn about new and innovative research and practice initiatives, and promote the role of the pharmacist in enhancing patient care. Take advantage of this unique member benefit and apply today!

Meet the APhA Science Officer

The APhA Science Officer is charged with prioritizing and coordinating the Association’s response to emerging and important scientific issues and assists in developing the Association’s official position on scientific, regulatory, and therapeutic issues. Patrick G. Clay, PharmD, FCCP, CCTI, is Professor of Pharmacotherapy at University of North Texas System College of Pharmacy and is a member of APhA-APRS Clinical Sciences Section.

Pharmacy News

The National Governors Association recently released The Expanding Role of Pharmacists in a Transformed Health Care System.  This report highlights how states can better integrate pharmacists into the health care system and is one more confirmation of the profession’s role in addressing the health care needs of patients.

Get Plugged Into APhA-APRS

Are you a new member to APhA-APRS? Or a current APhA-APRS member looking for ways to get more involved?Are you interested in the policy making process? Visit to learn more about the volunteer opportunities in APhA-APRS. 

APhA ENGAGE: Current Discussions

1 day ago
System wide PhORCAS issue (for those in Phase II)

For those of you in Phase II: I've had some back and forth with a candidate saying her application was completed. I called PhORCAS and they informed…

Read More
1 day ago
FDA Releases Draft Guidance for Comments: Bulk Drug Substances Nominated for Use at 503Bs.
Posted in: Compounding SIG

Hi, all. Today, the FDA released draft guidance:  Evaluation of Bulk DrugSubstances Nominated for Use inCompounding Under Section503B of the Federal…

Read More
1 day ago
In Search of Patient Cases

Good morning! I am looking for patient cases to assist with the teaching of residents on the following topics: AKI, High Risk Meds in the Elderly,…

Read More
1 day ago
Federal Spending Law Includes Important Compounding Clarifications.
Posted in: Compounding SIG

Greetings, everyone. Yesterday, the Congress passed a federal omnibus appropriations bill that funds the federal government through September 30.…

Read More

Join the APhA-APRS Community on Engage

Are you interested in the basic sciences, clinical sciences, or the economic, social, and administrative sciences? Join your fellow researchers and scientists today in the APhA-APRS online community on APhA Engage. Take full advantage of our interactive community platform! Follow these steps:
  1. Login on with your username and password.
  2. Click on "My Account".
  3. Select "Academies, Sections, and SIGs" on the left side of the page.
  4. Click on "Edit" on the right-hand side of the page.
  5. Under "Primary Academy", select "APhA-APRS".
  6. Under " APhA-APRS Special Interest Groups (APhA-APRS SIGs)", check your primary sections of interest.
  7. Once the above steps have been completed, visit APhA Engage at and JOIN your chosen SIG community(s) in APhA Engage.
3-minute video on accessing your profile, updating your information, and more!

Getting Started Video Library for APhA Engage, your members-only online discussion community

    Questions or suggestions for community-related content? Contact Margaret Tomecki at